Clinical Trial

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Recruiting
View on ClinicalTrials.gov →
Summary
Two dietary supplements are each being compared to a placebo for the ability to help maintain triglycerides in the normal range. The subjects will be adult men and women with moderately high TG values. Serum triglycerides will be measured before and after 6 weeks of taking 1 capsule per day of either Longvida Curcumin, astaxanthin, or a placebo. A few side blood analysis will also be done. These measures are relevant to low level inflammation.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-07-03; most recent amendment 2026-07-12.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT07063056
Lead Sponsor Medinutra LLC
Conditions Triglycerides
Enrollment 64 participants
Start Date 2025-07-18
Primary Completion 2026-09-25 (estimated)
Study Completion 2026-09-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-14